IMTX (Immatics NV) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 11, 2026)


IMTX Immatics NV IMTX
60 GF Score
Price $9.68
GF Value $3.40
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Immatics NV 5-Year Yield-on-Cost %?

Immatics NV IMTX -2.81% 60 5-Year Yield-on-Cost % is 0.00 as of Jul. 11, 2026. GuruFocus rates IMTX with a GF Score™ of 60/100 and a GF Value™ of $3.40 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 153 Biotechnology companies, Immatics NV ranks worse than 653594.12% on this metric.

Immatics NV's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for Immatics NV's 5-Year Yield-on-Cost % or its related term are showing as below:



IMTX's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.65
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Immatics NV  (NAS:IMTX) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Immatics NV 5-Year Yield-on-Cost % Related Terms


IMTX vs MNKD, JBIO, AVLN: 5-Year Yield-on-Cost % Comparison

For the Biotechnology subindustry, Immatics NV's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Immatics NV 5-Year Yield-on-Cost % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immatics NV's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Immatics NV's 5-Year Yield-on-Cost % falls into.


IMTX
60GF Score
Immatics NV IMTX
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Immatics NV 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Immatics NV is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Immatics NV (IMTX) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 11, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Immatics NV and its competitors. According to the industry distribution chart, Immatics NV ranks #999999 out of 153 companies in the Biotechnology industry.
Is Immatics NV's 5-Year Yield-on-Cost % too high?
Immatics NV's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Immatics NV ranks #999999 out of 153 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Immatics NV has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Immatics NV's 5-Year Yield-on-Cost % compare to MNKD and JBIO?
According to the Biotechnology industry distribution chart, Immatics NV ranks #999999 out of 153 companies for 5-Year Yield-on-Cost %. This places Immatics NV in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 1.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Biotechnology company?
The median 5-Year Yield-on-Cost % among Biotechnology companies is 1.65, based on 153 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Immatics NV and its competitors. For the Biotechnology industry, the median 5-Year Yield-on-Cost % is 1.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Immatics NV's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Immatics NV stock overvalued right now?
Based on GuruFocus' analysis, Immatics NV (IMTX) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.40, compared to a current price of $9.68 — trading 184.7% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Immatics NV's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Immatics NV (IMTX), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Immatics NV (IMTX) Overvalued in 2026?

Based on GuruFocus' analysis, Immatics NV stock appears to be overvalued. The current stock price of $9.68 is trading 184.7% above its estimated GF Value™ of $3.40. GuruFocus considers Immatics NV to be Significantly Overvalued.

Key valuation signals for IMTX:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: $3.40 vs. price of $9.68 (184.7% above fair value)
  • GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the IMTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Immatics NV Business Description

Other Exchanges 4A3:Germany
Address Paul-Ehrlich-Strasse 15, Tubingen, BW, DEU, 72076
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
60GF Score

Get the complete analysis for IMTX

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.68
Price
$3.40
GF Value